Cargando…
SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey
BACKGROUND: The first national severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurvey in India, done in May–June, 2020, among adults aged 18 years or older from 21 states, found a SARS-CoV-2 IgG antibody seroprevalence of 0·73% (95% CI 0·34–1·13). We aimed to assess the more recent...
Ejemplares similares
-
Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional study
por: Murhekar, Manoj V., et al.
Publicado: (2021) -
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021
por: Murhekar, Manoj V., et al.
Publicado: (2021) -
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020
por: Murhekar, Manoj V., et al.
Publicado: (2020) -
Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India
por: Selvaraju, Sriram, et al.
Publicado: (2021) -
Postoperative Fracture Risk in Giant Cell Tumor: A Case Report and Review of Literature
por: Kumar, Amit, et al.
Publicado: (2023)